Q1 IR Roundtable Event: How ESG Drives Trust Among Investors and Patients Alike

Published about 2 months ago • 1 min read

HI!

Regardless of whether IR is formally in your remit, ESG conversations are showing up everywhere right now... in earnings prep, in board discussions, in analyst questions, and increasingly in conversations about patient trust.

Investors are evaluating governance, capital discipline, and long-term risk. But in our industry, ESG carries a different weight because patients and advocacy communities are watching how companies show up on access, equity, and corporate responsibility.

That’s what T2B's Q1 IR Roundtable event will explore:

Beyond the Checkbox: How ESG Drives Trust Among Investors and Patients Alike

🗓️ Friday, March 13th | 12-12:45 p.m. ET
Sign up here
Exclusive to T2B Pro and Student members

We’ll explore:

How different types of investors are actually interpreting and applying ESG information
The role of ratings agencies and external benchmarks
Where ESG intersects with governance, DEI, access, and patient centricity
How IR and corporate affairs leaders are structuring the narrative so it holds up with analysts, boards, and employees alike

Our speakers bring perspective from biotech, large pharma, and strategic advisory roles:

Elizabeth Higgins, Former Head of Corporate Communications and Investor Relations, Astria Therapeutics, and T2B IR Roundtable Member
Sri Ramaswami, Founder and Principal, Sri Spoke Communications LLC
Moderated by David Connolly, Head of Investor Relations and Corporate Communications, Rhythm Pharmaceuticals, and T2B IR Roundtable Member

Looking forward to this one!

Lynnea

PS - I hope our friends on the East Coast are staying safe and warm amid the blizzard! We'll be rescheduling this week's meetups in Boston and Princeton soon.

Tomorrow: What Patient Groups Want Communicators to Understand

Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...

4 days ago • 1 min read

Understanding the Business of Biopharma Comms

Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...

6 days ago • 2 min read

What Do Patient Advocacy Groups Actually Need From Biopharma Comms?

Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...